The Wall Street Journal criticized all parties in Thailand's dispute with global drugmakers and said the entire matter sets a bad precedent for global property rights. In an editorial, the newspaper accused Thailand of stretching the facts in challenging patents of Abbott Laboratories and the drugmaker for undermining its own credibility by reversing itself under pressure.

Related Summaries